Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ambiante Health & Wellness vs TeleHealth Med

Ambiante Health & Wellness
Graded #448

Lower grade

vs+11.099999999999994
TeleHealth Med
Graded #209

Higher grade

The verdict

TeleHealth Med takes it — 66.1/100 to 55/100.

TeleHealth Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +29
45
74
Dose & formulationTeleHealth Med +23
40
63
Clinical oversightAmbiante Health & Wellness +2
78
76
Labs & monitoringAmbiante Health & Wellness +1
53
52
FulfillmentAmbiante Health & Wellness +2
65
63
Contract termsEven
55
55
Ambiante Health & Wellness · left barTeleHealth Med · right bar

The numbers

MetricAmbiante Health & WellnessTeleHealth Med
WeighScore55/10066.1/100
GradeCC
Scorecard rank#448#209
SemaglutideNot disclosed$147/mo (starting dose, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

Strengths

  • Compounded semaglutide and tirzepatide plus a low-dose GLP-1 "Longevity Microdose" option, all provider-guided
  • Concierge model: dedicated provider, direct secure messaging, provider-directed dosing, and structured check-ins
  • Every plan bundles compounded medication, provider care, and discreet direct delivery with no hidden fees
  • No charge if you are not approved; published support hours (Mon-Fri, 9am-5pm ET) by phone and email

Where it loses points

  • GLP-1 program pricing is not published on the site — quoted only after provider review, so cost is not comparable up front
  • Compounding pharmacy partners are not publicly named (a transparency gap for medication sourcing)
  • No brand-name Wegovy, Zepbound, Mounjaro, or Ozempic — compounded formulations only
  • State availability is not published; private-pay only, and the practice serves women, so it is not a fit for everyone
  • No LegitScript or PCAB accreditation displayed on the marketing site
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard